Send to

Choose Destination
Small. 2019 Jul 10:e1902011. doi: 10.1002/smll.201902011. [Epub ahead of print]

Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.

Author information

Department of Neurosurgery, Yale University, New Haven, CT, 06511, USA.
Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Department of Neurology, Yale University, New Haven, CT, 06510, USA.
Department of Neurosurgery, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China.


Cell membrane coating has recently emerged as a promising biomimetic approach to engineering nanoparticles (NPs) for targeted drug delivery. However, simple cell membrane coating may not meet the need for efficient drug delivery to the brain. Here, a novel molecular engineering strategy to modify the surface of NPs with a cell membrane coating for enhanced brain penetration is reported. By using poly(lactic-co-glycolic) acid NPs as a model, it is shown that delivery of NPs to the ischemic brain is enhanced through surface coating with the membrane of neural stem cells (NSCs), and the delivery efficiency can be further increased using membrane isolated from NSCs engineered for overexpression of CXCR4. It is found that this enhancement is mediated by the chemotactic interaction of CXCR4 with SDF-1, which is enriched in the ischemic microenvironment. It is demonstrated that the resulting CXCR4-overexpressing membrane-coated NPs, termed CMNPs, significantly augment the efficacy of glyburide, an anti-edema agent, for stroke treatment. The study suggests a new approach to improving drug delivery to the ischemic brain and establishes a novel formulation of glyburide that can be potentially translated into clinical applications to improve management of human patients with stroke.


CXCR4; glyburide; nanoparticles; neural stem cells; stroke


Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center